Kedaara gets over 5X returns from Vijaya Diagnostic

Premium

Homegrown private equity firm Kedaara is sitting on attractive annualized returns of 44% from its investment in IPO-bound Vijaya Diagnostics, according to VCCircle estimates. IPO-bound Vijaya Diagnostic Centre’s issue, which is purely an offer-for-sale of up to 35.69 million shares, will get the promoters and Kedaara up to Rs.1,895 crore. Kedaara, ......